Carregant...
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that is of great interest in human cancer. It has been shown to have a dual nature, as it can act as a gene repressor or activator. Studies have highlighted the various roles of EZH2 in the pathophysiology of multiple myeloma (MM). It...
Guardat en:
| Publicat a: | Biomark Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286605/ https://ncbi.nlm.nih.gov/pubmed/30555699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0148-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|